Silver-coated barrier dressing cleared by FDA
This article was originally published in Clinica
The US FDA has granted 510(k) marketing clearance for Acticoat Flex, an antimicrobial barrier dressing designed to treat injuries that require sustained antimicrobial activity. Acticoat Flex is coated with Silcryst, a nanocrystalline silver technology, and was developed by Nucryst Pharmaceuticals (Princeton, New Jersey) in collaboration with Smith & Nephew. The companies have a partnership to provide advanced antimicrobial protection to acute trauma and burn patients, as well as to patients with complex chronic wounds. Nucryst is also developing the nanocrystalline silver in a powder form, referred to as NPI 32101, for use in medical devices and as a pharmaceutical.